IMUX: Immunic, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | New 13G stake | OrbiMed Advisors LLC | 5.30% | SEC | |
| 2026-08-14 | 13G amendment | Nantahala Capital Management, LLC | 7.47% | SEC | |
| 2026-08-14 | 13G amendment | Commodore Capital LP | 9.90% | SEC | |
| 2026-08-13 | Fell below 5% | Soleus Capital Master Fund, L.P. | 4.90% | SEC | |
| 2026-08-06 | 13G amendment | Integrated Core Strategies (US) LLC | 7.00% | SEC | |
| 2026-08-04 | New 13G stake | Laurion Capital Management LP | 6.06% | SEC |
Institutional ownership (Q2 2026)
56 institutions reported holding $134.50M of Immunic, Inc. on Form 13F (3 the quarter before). 54 opened a new position and 1 sold out. Shares held by institutions: +818%.
| Largest holders | Shares | Value |
|---|---|---|
| Aberdeen Group plc | 824,393 | $12.67M |
| BVF INC/IL | 765,295 | $11.76M |
| MILLENNIUM MANAGEMENT LLC | 740,347 | $11.38M |
| Avidity Partners Management LP | 669,941 | $10.30M |
| BRAIDWELL LP | 645,010 | $9.91M |
| Laurion Capital Management LP | 610,326 | $9.38M |
| VANGUARD CAPITAL MANAGEMENT LLC | 571,561 | $8.78M |
| Jones Hill Capital LP | 539,814 | $8.30M |
| Nantahala Capital Management, LLC | 501,292 | $7.70M |
| Woodline Partners LP | 471,528 | $7.25M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.